Med-Chemist : "Quintessential Medicinal Chemistry"
Tuesday, March 9, 2021
Discovery of compound that reverses the fertility clock
›
Nicotinamide adenine dinucleotide ( NAD ) Nicotinamide mononucleotide (" NMN ", " N...
Saturday, March 6, 2021
FDA Approves Ukoniq (umbralisib) for Marginal Zone Lymphoma and Follicular Lymphoma
›
TG Therapeutics, Inc, announced the U.S. Food and Drug Administration (FDA) approval of Ukoniq (umbralisib), for the treatment of adult p...
Wednesday, March 3, 2021
Cabotegravir Injection Can Protect Women From HIV for Two Months
›
An experimental injection drug works better than daily pills to protect women from getting HIV from an infected sex partner, researchers s...
FDA Approves Tepmetko (tepotinib) as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations
›
EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, announced that the US Food and Drug Admi...
Tuesday, March 2, 2021
FDA Approves Cosela (trilaciclib) to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
›
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, announced the U.S. Food and Drug Administration (FDA) approva...
Monday, March 1, 2021
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45
›
In continuation of my update on antisense oligonucleotides Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare d...
Wednesday, February 10, 2021
FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
›
Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel th...
1 comment:
Tuesday, February 9, 2021
FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
›
Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that the U.S. Food and...
Monday, February 8, 2021
FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)
›
Urovant Sciences (Nasdaq: UROV) announced the U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for on...
Saturday, February 6, 2021
FDA Approves Orladeyo (berotralstat) as the First Oral, Once-Daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
›
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced the U.S. Food and Drug Administration (FDA) approval of oral, once-daily Orladeyo ...
Friday, February 5, 2021
Oral Azacitidine Benefits Some Older Adults With AML
›
In continuation of my update on azacitidine For older patients with acute myeloid leukemia (AML) who are in remission after chemotherapy, t...
Wednesday, February 3, 2021
Drug discovery study identifies promising new compound to open constricted airways
›
Despite the progress made in managing asthma and chronic obstructive pulmonary disease (COPD), poorly controlled symptoms for both respirato...
Monday, February 1, 2021
New drug form may help treat osteoporosis, calcium-related disorders
›
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients...
‹
›
Home
View web version